// App-Quantinova.ai

6520 : The economic impact of the transition from branded to generic oncology drugs.

Researchers

Presenter

  • Winson Y. Cheung

Principal Investigators

  • Nicole Mittmann

  • Natasha B. Leighl

  • Matthew C. Cheung

  • Penelope Ann Bradbury

  • Raymond C.H. Ng

  • Bingshu E. Chen

  • Keyue Ding

  • Joseph L Pater

  • Dongsheng Tu

  • Annette E. Hay

Medical Centers

  • BC Cancer Agency, Vancouver, BC, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • National Cancer Centre Singapore, Singapore, Singapore

  • Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada

  • NCIC Clinical Trials Group, Kingston, ON, Canada

  • Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada

Locations

  • Canada

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved